Maria Sainz - 11 Jun 2026 Form 4 Insider Report for PULSE BIOSCIENCES, INC. (PLSE)

Reporting relationship: Director
Issuer ticker: PLSE
Reported as of: 11 Jun 2026
Net transaction value: $0
SEC form: 4
Accepted by SEC: 15 Jun 2026, 20:54:57 UTC
Prior SEC filing: 01 Apr 2026
Source filing: View source filing
Reporting owner signature: /s/ Kenneth B. Stratton

Key filing fact

Maria Sainz filed Form 4 for PULSE BIOSCIENCES, INC. (PLSE) on 15 Jun 2026.

Key facts

This page summarizes Maria Sainz's Form 4 filing for PULSE BIOSCIENCES, INC. (PLSE).
2 reported transactions and 2 derivative rows are listed below.
Accepted by SEC: 15 Jun 2026, 20:54.

Change

Previous filing in this sequence was filed on 01 Apr 2026.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001437768 Primary reporting owner

Sainz Maria

Relationship: Director
Address: C/O PULSE BIOSCIENCES, INC., 3957 POINT EDEN WAY, HAYWARD
Signature: /s/ Kenneth B. Stratton
Signature date: 15 Jun 2026

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

PLSE transaction Derivative

Stock Option (right to buy)

Award

Transaction value
Shares: +30,000
Change %
Price: $0.000000^*
Shares after: 30,000
Date: 11 Jun 2026
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 30,000
Exercise price: $26.89
Footnotes: F1

PLSE transaction Derivative

Stock Option (right to buy)

Award

Transaction value
Shares: +3,793
Change %
Price: $0.000000^*
Shares after: 3,793
Date: 11 Jun 2026
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 3,793
Exercise price: $26.89
Footnotes: F2

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 2 footnotes

Footnote F1

The shares subject to the option will vest in equal monthly installments over a one-year period, subject to the Reporting Person's continued service through each vesting date, with the first such installment occurring on July 11, 2026.

Footnote F2

The shares subject to the option will vest in equal quarterly installments over a one-year period, subject to the Reporting Person's continued service through each vesting date, with the first such installment occurring on September 5, 2026.